1. Whole-genome sequencing analysis of semi-supercentenarians.
- Author
-
Garagnani P, Marquis J, Delledonne M, Pirazzini C, Marasco E, Kwiatkowska KM, Iannuzzi V, Bacalini MG, Valsesia A, Carayol J, Raymond F, Ferrarini A, Xumerle L, Collino S, Mari D, Arosio B, Casati M, Ferri E, Monti D, Nacmias B, Sorbi S, Luiselli D, Pettener D, Castellani G, Sala C, Passarino G, De Rango F, D'Aquila P, Bertamini L, Martinelli N, Girelli D, Olivieri O, Giuliani C, Descombes P, and Franceschi C
- Subjects
- Aged, Aged, 80 and over, Cohort Studies, Female, Genetic Background, Humans, Italy, Male, Middle Aged, Mutation, Whole Genome Sequencing methods, Clonal Hematopoiesis genetics, DNA Repair, Longevity genetics, Whole Genome Sequencing statistics & numerical data
- Abstract
Extreme longevity is the paradigm of healthy aging as individuals who reached the extreme decades of human life avoided or largely postponed all major age-related diseases. In this study, we sequenced at high coverage (90X) the whole genome of 81 semi-supercentenarians and supercentenarians [105+/110+] (mean age: 106.6 ± 1.6) and of 36 healthy unrelated geographically matched controls (mean age 68.0 ± 5.9) recruited in Italy. The results showed that 105+/110+ are characterized by a peculiar genetic background associated with efficient DNA repair mechanisms, as evidenced by both germline data (common and rare variants) and somatic mutations patterns (lower mutation load if compared to younger healthy controls). Results were replicated in a second independent cohort of 333 Italian centenarians and 358 geographically matched controls. The genetics of 105+/110+ identified DNA repair and clonal haematopoiesis as crucial players for healthy aging and for the protection from cardiovascular events., Competing Interests: PG, MD, CP, EM, KK, VI, LX, DM, BA, MC, EF, DM, BN, SS, DL, DP, GC, CS, GP, FD, PD, LB, NM, DG, OO, CG, CF No competing interests declared, JM, AV, JC, FR, SC, PD is affiliated with Nestlé Research, Société des Produits Nestlé SA. The author has no other competing interests to declare. MB s affiliated with Nestlé Research, Société des Produits Nestlé SA. The author has no other competing interests to declare. AF is affiliated with Menarini Silicon Biosystems SpA. The author has no other competing interests to declare., (© 2021, Garagnani et al.)
- Published
- 2021
- Full Text
- View/download PDF